Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Institutions
Pharmaceutical companies
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

For organisations

Hospitals
Universities and medical schools
Pharmaceutical companies

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

International journal of molecular sciences

RETRACTED: Abou-ElNaga et al. Novel Nano-Therapeutic Approach Actively Targets Human Ovarian Cancer Stem Cells After Xenograft into Nude Mice. Int. J. Mol. Sci. 2017, 18, 813

20 October 2026Review1 min read

By Abou-ElNaga A, Mutawa G, El-Sherbiny IM and 4 others.

Read the original

On this page

Abstract
Authors
Source

Abstract

The journal retracts the article titled "Novel Nano-Therapeutic Approach Actively Targets Human Ovarian Cancer Stem Cells after Xenograft into Nude Mice" [...].

Authors

Abou-ElNaga A
Mutawa G
El-Sherbiny IM
Abd-ElGhaffar H
Allam AA
Ajarem J
Mousa SA

Source

Published in International journal of molecular sciences. The abstract is shown as published and remains the work of its authors; read the full article at the source.

Read around a topic while you study.

Ward brings these articles into the same app as your cards and questions. One free account for Ward, Suture, Osler and Prognia.

pubmed.ncbi.nlm.nih.gov/42910545/

Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.

At a glance

Journal: International journal of molecular sciences
Type: Review
Published: 20 October 2026
Specialty: Oncology
Read time: 1 min
Authors: 7
DOI: 10.3390/ijms27209309
PubMed: 42910545

More in oncology

Assessment of the IPSS-M in chronic myelomonocytic leukemiaBlood Advances · 2026Added todayNew
The NAT10/acMedicine Plus · 2026Added todayNew
Multifunctional cascade nanosystem consumes glucose to trigger enhanced pyroptosis and cuproptosis for tumor immunotherapyMaterials Today Bio · 2026Added todayNew
Targeting histone methylation with ROS nanoparticles delivering PARPi prodrugs to amplify the stimulation of cGAS-STING for immunotherapy in ovarian cancerMaterials Today Bio · 2026Added todayNew
Deep Learning-Based Spatial Profiling Identifies MET-Associated Immune Exclusion and Therapeutic Vulnerability Underlying Racial Disparities in Head and Neck CancermedRxiv · 2026Added todayNew
ESMO and ASCO Consensus on Good Clinical Practice Guideline E6(R3): A Step Forward Towards Streamlining Clinical ResearchESMO open · 2026Added todayNew
A Rare Hepatoblastoma in a 10‐Year‐Old Boy Presenting With Tumor Rupture and Normal Alpha‐Fetoprotein Levels: A Case ReportClinical Case Reports · 2026Added todayNew
Assessing the Epidemiological Trend of Gastric Cancer: A Retrospective Analysis From a Tertiary Care Hospital in BangladeshHealth Science Reports · 2026Added todayNew
Incidence of adverse events of concomitant immune checkpoint inhibitors and ultra hypo-fractionated radiotherapy: systematic review and meta-analysisClinical and Translational Radiation Oncology · 2026Added todayNew
Fractions of disadvantage: A comment on Houdou et alClinical and Translational Radiation Oncology · 2026Added todayNew
Efficacy and safety of intrathecal chemotherapy in leptomeningeal disease: a global retrospective multicenter analysis and review of the literatureEClinicalMedicine · 2026Added todayNew
Comparing patients’ perceptions and cognitive and emotional responses to pretest cancer genetic services delivered via chatbot vs standard of care: Findings from the BRIDGE trialGenetics in Medicine Open · 2026Added todayNew

Articles
Oncology